A number of lawsuits have been filed over Risperdal, an antipsychotic medication marketed by Johnson & Johnson’s Janssen Pharmaceuticals. Plaintiffs allege that the drug caused gynecomastia, or abnormal breast growth, in adolescent boys. The suits allege that J&J knew about these risks but failed to disclose them to patients, … [Read more...] about Jurors Told that J&J Obscured Risperdal Gynecomastia Data